nodes	percent_of_prediction	percent_of_DWPC	metapath
Icatibant—BDKRB2—nervous system—attention deficit hyperactivity disorder	0.0492	0.158	CbGeAlD
Icatibant—ANPEP—cardiovascular system—attention deficit hyperactivity disorder	0.0478	0.153	CbGeAlD
Icatibant—BDKRB2—central nervous system—attention deficit hyperactivity disorder	0.0474	0.152	CbGeAlD
Icatibant—BDKRB2—cerebellum—attention deficit hyperactivity disorder	0.0463	0.148	CbGeAlD
Icatibant—BDKRB2—brain—attention deficit hyperactivity disorder	0.0376	0.121	CbGeAlD
Icatibant—BDKRB2—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.0347	0.0505	CbGpPWpGaD
Icatibant—ANPEP—nervous system—attention deficit hyperactivity disorder	0.0307	0.0984	CbGeAlD
Icatibant—ANPEP—central nervous system—attention deficit hyperactivity disorder	0.0296	0.0947	CbGeAlD
Icatibant—ANPEP—brain—attention deficit hyperactivity disorder	0.0235	0.0752	CbGeAlD
Icatibant—BDKRB2—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.0233	0.0339	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0216	0.0314	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0212	0.0308	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.021	0.0306	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0185	0.0269	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0182	0.0264	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.0158	0.023	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.0147	0.0213	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.0141	0.0205	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.0138	0.0201	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.0138	0.0201	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.0128	0.0187	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.0126	0.0183	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.0125	0.0181	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.0122	0.0178	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.0121	0.0176	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.0119	0.0173	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.0119	0.0173	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.0116	0.0168	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.0114	0.0165	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.0113	0.0164	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.0112	0.0163	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.011	0.016	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.0108	0.0157	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.0105	0.0152	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—EP300—attention deficit hyperactivity disorder	0.0104	0.0151	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0102	0.0149	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.0099	0.0144	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00973	0.0141	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00961	0.014	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00958	0.0139	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00947	0.0138	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00895	0.013	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00847	0.0123	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00837	0.0122	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00797	0.0116	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00781	0.0114	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00779	0.0113	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00754	0.011	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00741	0.0108	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00732	0.0106	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00732	0.0106	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00724	0.0105	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00709	0.0103	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00682	0.00991	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00638	0.00927	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—EP300—attention deficit hyperactivity disorder	0.00632	0.00919	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00627	0.00912	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00541	0.00787	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00498	0.00724	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00492	0.00715	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00478	0.00694	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00473	0.00688	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.0044	0.0064	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.0043	0.00625	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00428	0.00622	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00426	0.00619	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00419	0.00609	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00419	0.00609	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00414	0.00601	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00411	0.00597	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.004	0.00581	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00387	0.00562	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00385	0.0056	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.0038	0.00553	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00376	0.00546	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.0035	0.00509	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.0029	0.00422	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.0027	0.00392	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00254	0.00369	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00245	0.00356	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00236	0.00343	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00229	0.00332	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00225	0.00327	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00222	0.00323	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00207	0.00301	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00145	0.0021	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000767	0.00112	CbGpPWpGaD
